SWOG clinical trial number
SWOG-7639

Two Adriamycin, Mitomycin-C and 5-Fluorouracil Com- bination in the Management of Gastric Adenocarcinoma

Closed
Abbreviated Title
Two Adriamycin, Mitomycin-C and 5-Fluorouracil Com- bination in the Management of Gastric Adenocarcinoma
Activated
02/15/1977
Closed
01/17/1979

Publication Information Expand/Collapse

1984

Drug combinations in the treatment of gastric adenocarcinoma: A Southwest Oncology Group study.

FJ Panettiere;C Haas;B McDonald;JJ Costanzi;RW Talley;J Athens;N Oishi;LK Heilbrun;TT Chen J Clin Oncol 2:420-424

1980

Southwest Oncology Group experience with two different schedules of 5-FU, Adriamycin and Mitomycin C (FAM) in the management of gastric carcinoma.

FJ Panettiere;LK Heilbrun American College of Physicians Air Force Regional Meeting 46

1979

Experiences with two treatment schedules in the combination chemotherapy of advanced gastric carcinoma.

FJ Panettiere;L Heilbrun In: Mitomycin-C - Current Status and New Developments. Chapter 16, pp. 145-157; Academic Press Inc (October 15, 1979); SK Carter, ST Cooke, eds.

Comparison of two different combination of Adriamycin, mitomycin-C and 5-FU in the treatment of gastric carcinoma.

F Panettiere;L Heilbrun ASCO #C-102